COL3A1, collagen type III alpha 1 chain, 1281

N. diseases: 301; N. variants: 402
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.310 GeneticVariation disease BEFREE In this study, we investigated whether single nucleotide polymorphisms (SNPs) of COL3A1 confer genetic susceptibility to patients with hepatitis B virus-infected liver diseases including chronic hepatitis B (CH), liver cirrhosis (CIR), and hepatocellular carcinoma (HCC). 19000145 2008
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.310 Biomarker disease CTD_human Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis. 16679477 2006
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.310 Biomarker disease CTD_human Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen. 15787813 2005
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.310 Biomarker disease CTD_human The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up. 11167689 2001
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.310 Biomarker disease CTD_human Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis. 1880254 1991
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.310 Biomarker disease CTD_human Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics. 2566230 1989